Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

U.S. shares, dollar pare losses after healthcare bill pulled

Published 24/03/2017, 21:07
Updated 24/03/2017, 21:07
© Reuters. Traders work on the floor of the NYSE

By Sam Forgione

NEW YORK (Reuters) - U.S. shares pared losses to end slightly lower on Friday after Republicans pulled their bill to overhaul the U.S. healthcare system due to a shortage of votes, dealing a blow to U.S. President Donald Trump, while European shares fell ahead of the decision.

The benchmark U.S. S&P 500 stock index ended a touch lower after falling as much as 0.4 percent earlier, before a House Republican leadership aide said the bill to dismantle Obamacare had been pulled by U.S. House Republican leadership. Traders were on tenterhooks during most of the session as they awaited the outcome of the vote.

European stocks slipped as caution prevailed ahead of the decision, with the FTSEurofirst 300 index of top European shares falling about 0.5 percent for the week.

But many analysts and investors have seen a failure of the bill as a catalyst to bring forward action on pro-growth policies such as tax reform, deregulation and infrastructure spending.

"The market is taking it as a positive that they are not pursuing something that looked like it was hitting a brick wall, and that means it’s more likely they can move on to other issues the market would like such as deregulation and lower taxes," said Margaret Patel, senior portfolio manager at Wells Fargo (NYSE:WFC) Asset Management in Boston.

MSCI's all-country world equity index (MIWD00000PUS) was last up 0.24 point, or 0.05 percent, at 447.72.

The Dow Jones Industrial Average (DJI) closed down 59.86 points, or 0.29 percent, at 20,596.72. The S&P 500 (SPX) closed down 1.98 points, or 0.08 percent, at 2,343.98. The Nasdaq Composite (IXIC) ended 11.05 points higher, or 0.19 percent, at 5,828.74.

Europe's broad FTSEurofirst 300 index (FTEU3) closed down 0.16 percent at 1,484.54.

The U.S. dollar index (DXY), which measures the greenback against a basket of six major rivals, hit a seven-week low of 99.527 before the healthcare decision but pared losses after the announcement and was last marginally higher at 99.765. [nL2N1H11DC]

"If this stronger dollar has legs, it depends on the next step," said Paresh Upadhyaya, director of currency strategy at Pioneer Investments in Boston. "If there is a pivot to taxes from healthcare, the market has to see the plan.”

Safe-haven assets such as gold, U.S. Treasuries and the yen lost some shine after the decision. Spot gold prices pared gains to last trade little changed at $1,245.37 an ounce after hitting a more than three-week high on Thursday of $1,253.12.[nL2N1H11G1]

The dollar was last up 0.3 percent <JPY=> against the yen at 111.25 yen after touching a four-month low of 110.64 yen before the decision.

Benchmark 10-year U.S. Treasuries prices turned flat (US10YT=RR) after the decision, with their yields last at 2.418 percent after hitting a session low of 2.393 percent earlier.

Oil rose modestly in a spate of late-day activity, but fell on the week as concerns persisted over an excess of crude.[nL3N1H11U6]

© Reuters. Traders work on the floor of the NYSE

Brent crude (LCOc1) settled up 24 cents, or 0.47 percent, at $50.80 a barrel. U.S. crude (CLc1) settled up 27 cents, or 0.57 percent, at $47.97.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.